These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32995704)

  • 1. Therapeutic Anticoagulation Delays Death in COVID-19 Patients: Cross-Sectional Analysis of a Prospective Cohort.
    Ionescu F; Grasso-Knight G; Castillo E; Naeem E; Petrescu I; Imam Z; Patel VK; Narasimhan M; Nair GB
    TH Open; 2020 Jul; 4(3):e263-e270. PubMed ID: 32995704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of anticoagulation dose and survival in hospitalized COVID-19 patients: A retrospective propensity score-weighted analysis.
    Ionescu F; Jaiyesimi I; Petrescu I; Lawler PR; Castillo E; Munoz-Maldonado Y; Imam Z; Narasimhan M; Abbas AE; Konde A; Nair GB
    Eur J Haematol; 2021 Feb; 106(2):165-174. PubMed ID: 33043484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-molecular-weight heparin compared with unfractionated heparin in critically ill COVID-19 patients.
    Volteas P; Drakos P; Alkadaa LN; Cleri NA; Asencio AA; Oganov A; Giannopoulos S; Saadon JR; Mikell CB; Rubano JA; Labropoulos N; Tassiopoulos AK; Mofakham S; Bannazadeh M
    J Vasc Surg Venous Lymphat Disord; 2022 Sep; 10(5):1128-1136. PubMed ID: 35716998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Empiric use of anticoagulation in hospitalized patients with COVID-19: a propensity score-matched study of risks and benefits.
    Yu B; Gutierrez VP; Carlos A; Hoge G; Pillai A; Kelly JD; Menon V
    Biomark Res; 2021 May; 9(1):29. PubMed ID: 33933168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Systemic Anticoagulation in COVID-19: Delving Beyond Theoretical Hypothesis.
    Millet C; Narvaneni S; Shafeek F; Roman S; Mechineni A; Manickam R
    Cureus; 2022 Feb; 14(2):e22061. PubMed ID: 35340525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulant Treatment Regimens in Patients With Covid-19: A Meta-Analysis.
    Jorda A; Siller-Matula JM; Zeitlinger M; Jilma B; Gelbenegger G
    Clin Pharmacol Ther; 2022 Mar; 111(3):614-623. PubMed ID: 34862791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic versus therapeutic dose anticoagulation effects on survival among critically ill patients with COVID-19.
    Hoogenboom WS; Lu JQ; Musheyev B; Borg L; Janowicz R; Pamlayne S; Hou W; Duong TQ
    PLoS One; 2022; 17(1):e0262811. PubMed ID: 35045130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials.
    Ortega-Paz L; Galli M; Capodanno D; Franchi F; Rollini F; Bikdeli B; Mehran R; Montalescot G; Gibson CM; Lopes RD; Andreotti F; Angiolillo DJ
    Eur Heart J Cardiovasc Pharmacother; 2022 Sep; 8(7):677-686. PubMed ID: 34519777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic vs. prophylactic anticoagulation in COVID-19 patients: a systematic review and meta-analysis of real-world studies.
    Vio R; Giordani AS; Stefil M; Alturki A; Russo V; China P; Gasperetti A; Schiavone M; Čulić V; Biondi-Zoccai G; Themistoclakis S; Lip GY; Proietti R
    Minerva Cardiol Angiol; 2022 Dec; 70(6):652-662. PubMed ID: 36305780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of therapeutic versus prophylactic anticoagulation therapy on clinical outcomes in COVID-19 patients: a systematic review with an updated meta-analysis.
    Duo H; Li Y; Sun Y; Wei L; Wang Z; Fang F; Zhong Y; Huang J; Luo L; Peng Z; Pan H
    Thromb J; 2022 Aug; 20(1):47. PubMed ID: 35999599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of anticoagulation on clinical outcomes in novel Coronavirus (COVID-19) pneumonia in a U.S. cohort.
    Lynn L; Reyes JA; Hawkins K; Panda A; Linville L; Aldhahri W; Kango G; Shah S; Ayanian S; Teufel K
    Thromb Res; 2021 Jan; 197():65-68. PubMed ID: 33186849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19.
    Nadkarni GN; Lala A; Bagiella E; Chang HL; Moreno PR; Pujadas E; Arvind V; Bose S; Charney AW; Chen MD; Cordon-Cardo C; Dunn AS; Farkouh ME; Glicksberg BS; Kia A; Kohli-Seth R; Levin MA; Timsina P; Zhao S; Fayad ZA; Fuster V
    J Am Coll Cardiol; 2020 Oct; 76(16):1815-1826. PubMed ID: 32860872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does High-Dose Thromboprophylaxis Improve Outcomes in COVID-19 Patients? A Meta-analysis of Comparative Studies.
    Elsebaie MAT; Baral B; Elsebaie M; Shrivastava T; Weir C; Kumi D; Birch NW
    TH Open; 2022 Oct; 6(4):e323-e334. PubMed ID: 36299621
    [No Abstract]   [Full Text] [Related]  

  • 14. Early initiation of prophylactic anticoagulation for prevention of COVID-19 mortality: a nationwide cohort study of hospitalized patients in the United States.
    Rentsch CT; Beckman JA; Tomlinson L; Gellad WF; Alcorn C; Kidwai-Khan F; Skanderson M; Brittain E; King JT; Ho YL; Eden S; Kundu S; Lann MF; Greevy RA; Ho PM; Heidenreich PA; Jacobson DA; Douglas IJ; Tate JP; Evans SJ; Atkins D; Justice AC; Freiberg MS
    medRxiv; 2020 Dec; ():. PubMed ID: 33330896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial therapeutic anticoagulation with rivaroxaban compared to prophylactic therapy with heparins in moderate to severe COVID-19: results of the COVID-PREVENT randomized controlled trial.
    Rauch-Kröhnert U; Puccini M; Placzek M; Beyer-Westendorf J; Jakobs K; Friebel J; Hein S; Seidel M; Pieske B; Massberg S; Witzenrath M; Zeiher A; Friede T; Anker SD; Landmesser U
    Clin Res Cardiol; 2023 Nov; 112(11):1620-1638. PubMed ID: 37407731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial.
    Lopes RD; de Barros E Silva PGM; Furtado RHM; Macedo AVS; Bronhara B; Damiani LP; Barbosa LM; de Aveiro Morata J; Ramacciotti E; de Aquino Martins P; de Oliveira AL; Nunes VS; Ritt LEF; Rocha AT; Tramujas L; Santos SV; Diaz DRA; Viana LS; Melro LMG; de Alcântara Chaud MS; Figueiredo EL; Neuenschwander FC; Dracoulakis MDA; Lima RGSD; de Souza Dantas VC; Fernandes ACS; Gebara OCE; Hernandes ME; Queiroz DAR; Veiga VC; Canesin MF; de Faria LM; Feitosa-Filho GS; Gazzana MB; Liporace IL; de Oliveira Twardowsky A; Maia LN; Machado FR; de Matos Soeiro A; Conceição-Souza GE; Armaganijan L; Guimarães PO; Rosa RG; Azevedo LCP; Alexander JH; Avezum A; Cavalcanti AB; Berwanger O;
    Lancet; 2021 Jun; 397(10291):2253-2263. PubMed ID: 34097856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous thromboembolism in critically ill COVID-19 patients receiving prophylactic or therapeutic anticoagulation: a systematic review and meta-analysis.
    Hasan SS; Radford S; Kow CS; Zaidi STR
    J Thromb Thrombolysis; 2020 Nov; 50(4):814-821. PubMed ID: 32748122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermediate- vs. Standard-Dose Prophylactic Anticoagulation in Patients With COVID-19 Admitted in Medical Ward: A Propensity Score-Matched Cohort Study.
    Smadja DM; Bonnet G; Gendron N; Weizman O; Khider L; Trimaille A; Mirault T; Fauvel C; Diehl JL; Mika D; Philippe A; Pezel T; Goudot G; Sutter W; Planquette B; Waldmann V; Sanchez O; Cohen A; Chocron R
    Front Med (Lausanne); 2021; 8():747527. PubMed ID: 34722585
    [No Abstract]   [Full Text] [Related]  

  • 19. Anticoagulation and In-Hospital Mortality From Coronavirus Disease 2019: A Systematic Review and Meta-Analysis.
    Moonla C; Sosothikul D; Chiasakul T; Rojnuckarin P; Uaprasert N
    Clin Appl Thromb Hemost; 2021; 27():10760296211008999. PubMed ID: 33874753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Anticoagulants and Antiplatelets in Reducing Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis of Studies Reporting Adjusted Data.
    Ram MD; Umer M; Trada IJ; Khan SJ; Imran L; Rehan T; Hassan W; Zafar F; Razak S; Laeeq T; Aijaz P; Majid Z
    Cureus; 2023 Sep; 15(9):e45749. PubMed ID: 37872904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.